The Protective Effect of Transcription Factor 7-Like 2 Risk Allele rs7903146 against Elevated Fasting Plasma Triglyceride in Type 2 Diabetes: A Meta-Analysis

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Wang, Shuxia ^a   Song, Kangxing ^a   Srivastava, Roshni ^b   Fathzadeh, Mohsen ^a,b   Li, Na ^b   Mani, Arya ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL; TCF7L2 PROTEIN, HUMAN;

ALGORITHM; DATA BASE; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ALLELE; BLOOD; DIET RESTRICTION; GENETIC PREDISPOSITION; GENETICS;

ALLELES; DIABETES MELLITUS, TYPE 2; FASTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRIGLYCERIDES;

EID: 84947475041     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/468627     Document Type: Review

References (43)

1. A. Garg and V. Simha, "Update on dyslipidemia, " The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 5, pp. 1581-1589, 2007.
2. A. J. Lusis, R. Mar, and P. Pajukanta, "Genetics of atherosclerosis, " Annual Review of Genomics and Human Genetics, vol. 5, pp. 189-218, 2004.
3. R. L. Pollex and R. A. Hegele, "Genomic copy number variation and its potential role in lipoprotein andmetabolic phenotypes, " Current Opinion in Lipidology, vol. 18, no. 2, pp. 174-180, 2007.
4. S. Schinner, "Wnt-signalling and the metabolic syndrome, " Hormone and Metabolic Research, vol. 41, no. 2, pp. 159-163, 2009.
5. S. F. A. Grant, G. Thorleifsson, I. Reynisdottir et al. , "Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes, " Nature Genetics, vol. 38, no. 3, pp. 320-323, 2006.
6. H. Dou, E. Ma, L. Yin, Y. Jin, and H. Wang, "The association between gene polymorphism of TCF7L2 and type 2 diabetes in chinese han population: A meta-Analysis, " PLoS ONE, vol. 8, no. 3, Article ID e59495, 2013.
7. S. Peng, Y. Zhu, B. Lü, F. Xu, X. Li, and M. Lai, "TCF7L2 gene polymorphisms and type 2 diabetes risk: A comprehensive and updated meta-Analysis involving 121, 174 subjects, " Mutagenesis, vol. 28, no. 1, pp. 25-37, 2013.
8. P. Perez-Martinez, A. I. Perez-Caballero, A. Garcia-Rios et al. , "Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations, " PLoS ONE, vol. 7, no. 8, Article ID e43390, 2012.
9. D. Warodomwichit, D. K. Arnett, E. K. Kabagambe et al. , "Polyunsaturated fatty acidsmodulate the effect of TCF7L2 gene variants on postprandial lipemia, " The Journal of Nutrition, vol. 139, no. 3, pp. 439-446, 2009.
10. A. G. P. Sousa, G. F. Marquezine, P. A. Lemos et al. , "TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality, " PLoS ONE, vol. 4, no. 11, Article ID e7697, 2009.
11. D. Melzer, A. Murray, A. J. Hurst et al. , "Effects of the diabetes linked TCF7L2 polymorphism in a representative older population, " BMC Medicine, vol. 4, article 34, 2006.
12. A. Muendlein, C. H. Saely, S. Geller-Rhomberg et al. , "Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis, " PLoS ONE, vol. 6, no. 3, Article ID e17978, 2011.
13. A. Palizban, M. Nikpour, R. Salehi, and M.-R. Maracy, "Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in a Persian population, " Clinical and Experimental Medicine, vol. 12, no. 2, pp. 115-119, 2012.
14. C. Then, S. Wahl, A. Kirchhofer et al. , "Plasma metabolomics reveal alterations of sphingo-And glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146, " PLoS ONE, vol. 8, no. 10, Article ID e78430, 2013.
15. C. Kahveci, M. Koldemir, P. Cagatay et al. , "Relationship of transcription factor 7 like 2 gene rs7903146 variation with type 2 diabetes and obesity related parameters, " Diabetes & Metabolic Syndrome, vol. 6, no. 1, pp. 48-53, 2012.
16. D. Bodhini, V. Radha, M. Dhar, N. Narayani, and V. Mohan, "The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associatedwith type 2 diabetes mellitus in Asian Indians, " Metabolism: Clinical and Experimental, vol. 56, no. 9, pp. 1174-1178, 2007.
17. G. F. Marquezine, A. C. Pereira, A. G. P. Sousa, J. G. Mill, W. A. Hueb, and J. E. Krieger, "TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population, " BMC Medical Genetics, vol. 9, article 106, 2008.
18. G. Musso, R. Gambino, G. Pacini, G. Pagano, M. Durazzo, and M. Cassader, "Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH, " Hepatology, vol. 49, no. 2, pp. 426-435, 2009.
19. H. J. Choi, D.-H. Lee, H. J. Jeon, D. S. Kim, Y. H. Lee, and T. Oh, "Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration, " Diabetes Research and Clinical Practice, vol. 103, no. 3, pp. e3-e6, 2014.
20. J. Wang, L. Li, J. Zhang et al. , "Association of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms in TCF7L2 with type 2 diabetes in 9, 619 Han Chinese population, " PLoS ONE, vol. 8, no. 3, Article ID e59053, 2013.
21. J. Delgado-Lista, P. Perez-Martinez, A. Garćia-Rios et al. , "Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study, " Atherosclerosis, vol. 214, no. 1, pp. 110-116, 2011.
22. R. B. Ramos, D. Wiltgen, and P. M. Spritzer, "Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: A Cross-sectional study, " European Journal of Endocrinology, vol. 169, no. 5, pp. 569-576, 2013.
23. R. Gambino, S. Bo, L. Gentile et al. , "Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult italian population-based cohort, " Diabetes Care, vol. 33, no. 6, pp. 1233-1235, 2010.
24. S. Cauchi, D. Meyre, H. Choquet et al. , "TCF7L2 rs7903146 variant does not associate with smallness for gestational age in the French population, " BMCMedical Genetics, vol. 8, article 37, 2007.
25. S. Cauchi, D. Meyre, H. Choquet et al. , "TCF7L2 variation predicts hyperglycemia incidence in a French general population: The data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study, " Diabetes, vol. 55, no. 11, pp. 3189-3192, 2006.
26. S. E. Humphries, D. Gable, J. A. Cooper et al. , "Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbeanmenandwomen, " Journal ofMolecularMedicine, vol. 84, no. 12, pp. 1005-1014, 2006.
27. S. Bo, R. Gambino, G. Ciccone et al. , "Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention, " The American Journal of Clinical Nutrition, vol. 90, no. 6, pp. 1502-1508, 2009.
28. S. Ereqat, A. Nasereddin, S. Cauchi, K. Azmi, Z. Abdeen, and R. Amin, "Association of a common variant in TCF7L2 gene withtype2diabetesmellitus in thePalestinianpopulation, " Acta Diabetologica, vol. 47, supplement 1, pp. S195-S198, 2010.
29. Y. Yan, K. E. North, C. M. Ballantyne et al. , "Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and caucasian adults: The atherosclerosis risk in communities study, " Diabetes, vol. 58, no. 1, pp. 285-289, 2009.
30. Y. Yan, R. Klein, G. Heiss et al. , "The transcription factor 7-like 2 (TCF7L2) polymorphism may be associated with focal arteriolar narrowing in Caucasians with hypertension or without diabetes: The ARIC Study, " BMC Endocrine Disorders, vol. 10, article 9, 2010.
31. Z. Schroner, M. Javorsky, R. Tkacova et al. , "Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes, " Diabetes, Obesity & Metabolism, vol. 13, no. 1, pp. 89-91, 2011.
32. N. J. Welton, D. M. Caldwell, E. Adamopoulos, and K. Vedhara, "Mixed treatment comparison meta-Analysis of complex interventions: psychological interventions in coronary heart disease, " American Journal of Epidemiology, vol. 169, no. 9, pp. 1158-1165, 2009.
33. Y.-C. Chang, Y.-F. Chiu, L. L.-T. Ho et al. , "TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance, " Journal of Molecular Medicine, vol. 88, no. 2, pp. 183-192, 2010.
34. A. Huertas-Vazquez, C. Plaisier, D. Weissglas-Volkov et al. , "TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia, " Diabetologia, vol. 51, no. 1, pp. 62-69, 2008.
35. D. K. Sanghera, S. K. Nath, L. Ortega et al. , "TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels, " Annals of Human Genetics, vol. 72, no. 4, pp. 499-509, 2008.
36. C. L. Roth, A. Hinney, T. Reinehr et al. , "TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children, " Hormone and Metabolic Research, vol. 40, no. 10, pp. 713-717, 2008.
37. Y. Yan, K. E. North, G. Heiss et al. , "Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of impaired fasting glucose in African American and Caucasian adults: The atherosclerosis risk in communities (ARIC) study, " Diabetes/Metabolism Research and Reviews, vol. 26, no. 5, pp. 371-377, 2010.
38. V. Lyssenko, R. Lupi, P. Marchetti et al. , "Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes, "The Journal of Clinical Investigation, vol. 117, no. 8, pp. 2155-2163, 2007.
39. D. Savic, H. Ye, I. Aneas, S.-Y. Park, G. I. Bell, and M. A. Nobrega, "Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism, " Genome Research, vol. 21, no. 9, pp. 1417-1425, 2011.
40. D. T. Villareal, H. Robertson, G. I. Bell et al. , "TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action, " Diabetes, vol. 59, no. 2, pp. 479-485, 2010.
41. S. F. Boj, J. H. van Es, M. Huch et al. , "Diabetes risk gene and wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adultmetabolic demand, " Cell, vol. 151, no. 7, pp. 1595-1607, 2012.
42. G. Bardini, C. M. Rotella, and S. Giannini, "Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro-And macrovascular complications, " The Review of Diabetic Studies, vol. 9, no. 2-3, pp. 82-93, 2012.
43. G.-W. Go, R. Srivastava, A. Hernandez-Ono et al. , "The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed byWnt3a rescue, " Cell Metabolism, vol. 19, no. 2, pp. 209-220, 2014.